The data presented in this pilot study have identified a pattern of serum apolipoproteins which, in combination with CD5L, can discriminate pre-cirrhotic NAFLD, cirrhotic NAFLD, and cirrhotic NAFLD with HCC. The gene discussed is CD5L; the disease is hepatocellular carcinoma.